Avient Corporation

Informe acción NYSE:AVNT

Capitalización de mercado: US$3.0b

Salud financiera de hoja de balance de Avient

Salud financiera controles de criterios 3/6

Avient tiene un patrimonio de accionistas total de $2.4B y una deuda total de $1.9B, lo que sitúa su ratio deuda-patrimonio en 79.6%. Sus activos y pasivos totales son $5.9B y $3.5B respectivamente. El BAIT de Avient es de $379.7M, por lo que su ratio de cobertura de intereses es de 8.2. Tiene efectivo e inversiones a corto plazo que ascienden a $427.6M.

Información clave

79.59%

Ratio deuda-patrimonio

US$1.92b

Deuda

Ratio de cobertura de intereses8.2x
EfectivoUS$427.60m
PatrimonioUS$2.42b
Total pasivoUS$3.53b
Activos totalesUS$5.94b

Actualizaciones recientes sobre salud financiera

Recent updates

Actualización de narrativa Apr 22

AVNT: Future Crude Linked Cost Controls Will Support ReRating Potential

Analysts have maintained Avient’s fair value estimate at $48.57 while refining assumptions, including a slightly lower discount rate. This reflects recent price target increases from several firms, alongside a more cautious sector stance from others.
Actualización de narrativa Apr 08

AVNT: Future Crude Linked Cost Management Will Drive ReRating Potential

Analysts have modestly adjusted their price target on Avient to $48.57, with updated assumptions reflecting a slightly lower discount rate and broadly unchanged expectations for revenue growth, profit margins, and future P/E. Recent Street research cites higher crude linked input costs and mixed sector views, alongside higher individual firm targets up to $52.
Actualización de narrativa Mar 24

AVNT: Future Commodity Cost Management Will Drive ReRating Potential

Narrative Update The updated analyst price target for Avient edges lower by about $1, reflecting slightly higher discount rate assumptions and cautious views on raw material cost pressures. This comes even as several firms have recently lifted their individual targets following earnings and valuation roll-­forwards.
Actualización de narrativa Mar 08

AVNT: Future End Market Recovery And Higher P/E Are Expected To ReRate Shares

Narrative Update on Avient Our analyst price target for Avient edges up from $48.25 to $49.50 as analysts cite updated valuation work, including higher forward price targets and refined expectations for revenue growth, profit margins and future P/E multiples following recent sector and company specific research. Analyst Commentary Recent research on Avient shows a mix of optimism about the longer term setup and caution around near term input cost and industry headwinds.
Actualización de narrativa Feb 21

AVNT: Demand Recovery In Key End Markets Will Drive Future Multiple

The analyst fair value estimate for Avient has moved from $41.75 to $48.25, reflecting higher Street price targets as analysts update their models and adjust assumptions around future revenue growth, profit margins, and P/E multiples. Analyst Commentary Street research on Avient over the past few months has centered on revised valuation frameworks, longer dated earnings assumptions, and how quickly demand in key end markets might stabilize.
Artículo de análisis Feb 19

There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings

Avient Corporation's ( NYSE:AVNT ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...
Seeking Alpha Feb 18

Avient: Becoming A Better Business

Summary Avient has demonstrated solid operating momentum and resilient execution, with shares enjoying a notable re-rating amid challenging industry conditions. Avient's 2026 outlook targets adjusted EBITDA of $555–$585 million and an adjusted EPS midpoint of $3.05, driven by productivity and innovation, not macro recovery. Leverage has improved to 2.6x, and valuation has expanded to 14x adjusted earnings, reflecting investor confidence in management's strategy and product pipeline. Despite a 30% share price gain in six months, Avient remains reasonably valued, but further upside may prompt position trimming on strength. Read the full article on Seeking Alpha
Nueva narrativa Feb 16

Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook

Catalysts About Avient Avient supplies specialized materials and color and additive solutions for end markets such as health care, defense, telecommunications, packaging and transportation. What are the underlying business or industry changes driving this perspective?
Actualización de narrativa Feb 06

AVNT: Fair View Suggests Demand Recovery And Margins Will Drive Future Multiple

Narrative Update on Avient The analyst price target for Avient has been updated to US$41.75, a US$4.75 increase from the prior US$37 level. This change reflects a combination of higher targets from some firms and lower targets from others, as well as modest adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E.
Actualización de narrativa Jan 23

AVNT: Fair View Suggests Execution Will Shape Future Multiple Potential

Narrative Update on Avient The analyst price target for Avient has been adjusted slightly higher from $41.00 to $41.75, reflecting analysts’ updated views on earnings quality and valuation following recent target changes across the Street. Analyst Commentary Recent research updates on Avient present a mixed picture, with some analysts lifting targets and others trimming them, reflecting different views on how the company might execute in a challenging industry setup.
Actualización de narrativa Jan 08

AVNT: Reset Price View Will Support Future Multiple Expansion

Narrative Update Overview Analysts have trimmed their price target on Avient to US$36 from US$42, reflecting updated views on the shares while maintaining broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary on Avient centers on the reset in the price target to US$36.
Actualización de narrativa Dec 23

AVNT: Dividend And Buyback Execution Will Support Future Multiple Expansion

Avient's analyst price target has been reduced by $6 to $36, as analysts factor in more conservative expectations for the shares while maintaining a positive long term outlook. Analyst Commentary Analysts are recalibrating their expectations for Avient, balancing a still constructive long term view on execution and earnings power with a more tempered near term valuation framework.
Actualización de narrativa Dec 09

AVNT: New Leadership Will Drive 4% Organic Expansion As Cyclical Headwinds Ease

Avient's updated analyst price target has edged lower, reflecting a recalibration toward the mid 30 dollar to high 40 dollar range as analysts balance near term macro and cyclical pressures against improving margin prospects and the potential for faster organic growth under the new strategic focus. Analyst Commentary Recent Street research reflects a balanced mix of optimism around Avient's strategic pivot and caution on near term earnings power, resulting in a wide but grounded valuation range.
Actualización de narrativa Nov 24

AVNT: Renewed Leadership Will Drive Recovery With 4% Organic Expansion Ahead

Analysts have trimmed their price target for Avient by $1.13 to $41.00. This reflects cautious sentiment following reduced profit margin forecasts and recent reassessments of growth potential.
Actualización de narrativa Nov 07

AVNT: Renewed Leadership Will Drive Recovery In High-Growth End Markets

Analysts have modestly reduced their fair value estimate for Avient from $43.25 to $42.13. They cite a more conservative revenue growth outlook, even though profit margins and long-term growth opportunities continue to be supported by recent positive coverage and management strategy shifts.
Artículo de análisis Nov 05

Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275

The board of Avient Corporation ( NYSE:AVNT ) has announced that the dividend on 7th of January will be increased to...
Artículo de análisis Oct 12

Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275

Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.275 on...
Actualización de narrativa Sep 18

High-Performance Healthcare Materials And Sustainable Polymers Will Create Value

Analysts have raised Avient’s price target to $43.25, citing increased confidence in the new CEO’s strategic focus on high-growth markets, anticipated organic growth, and recovery potential in cyclical end markets. Analyst Commentary Increased optimism due to the new CEO's strategic focus on high-growth platforms and markets.
Artículo de análisis Sep 13

Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors

With a price-to-earnings (or "P/E") ratio of 27.9x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...
Artículo de análisis Jul 14

Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?

Key Insights Avient's estimated fair value is US$48.56 based on 2 Stage Free Cash Flow to Equity Current share price of...
Artículo de análisis May 23

Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?

Avient Corporation ( NYSE:AVNT ), might not be a large cap stock, but it saw a significant share price rise of 25% in...
Artículo de análisis May 08

Is Avient (NYSE:AVNT) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Artículo de análisis Apr 07

Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?

Key Insights Avient's estimated fair value is US$60.06 based on 2 Stage Free Cash Flow to Equity Avient's US$30.43...
Artículo de análisis Mar 23

Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E

With a price-to-earnings (or "P/E") ratio of 20.7x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...
Seeking Alpha Mar 22

Avient: Specialty Play Slowly Becomes More Special

Summary Avient Corporation has returned to growth in 2024, with promising projections for 2025, despite past disappointments and mixed earnings metrics. The company, specializing in material solutions, aims for organic growth and 20% EBITDA margins, but hasn't yet achieved these targets. Trading at $38 per share, Avient's valuation appears reasonable, but earnings will again be highly adjusted due to significant charges. While the 2025 outlook is strong, I remain cautious and seek a better entry point before initiating a long position. Read the full article on Seeking Alpha
Artículo de análisis Feb 19

At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?

While Avient Corporation ( NYSE:AVNT ) might not have the largest market cap around , it saw a decent share price...
Artículo de análisis Jan 20

Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Artículo de análisis Jan 03

An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued

Key Insights Avient's estimated fair value is US$57.96 based on 2 Stage Free Cash Flow to Equity Avient is estimated to...
Artículo de análisis Dec 18

Earnings Tell The Story For Avient Corporation (NYSE:AVNT)

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...
Artículo de análisis Nov 18

Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?

Avient Corporation ( NYSE:AVNT ), is not the largest company out there, but it saw a decent share price growth of 13...
Seeking Alpha Nov 13

Avient: Specialization Strategy Is Growing Margins And Driving The Bottom-Line Growth

Summary AVNT's gross profit margins have improved by over 70% in the last decade, indicating a shift to higher-margin specialty services. The company is focused on deleveraging, with share repurchases on hold until net debt-to-EBITDA reaches 2.5x, despite recent acquisitions. AVNT announced its 14th consecutive annual dividend increase, with a 5% hike, and aims to return to a safer payout ratio by 2026. With projected double-digit EPS growth and a potential P/E Ratio of 20.6x, AVNT is rated as a BUY with an estimated share price of $61.80 by the 2025 year-end. Read the full article on Seeking Alpha
Artículo de análisis Nov 02

Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27

Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.27 on...
Artículo de análisis Sep 26

Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
User avatar
Nueva narrativa Sep 02

Navigating Challenges, The Company Leverages Healthcare Innovations And Tactical Partnerships For Growth

Avient's strategy focuses on market share gain in varied sectors, especially healthcare, promising revenue growth with innovations like drug delivery devices.
Artículo de análisis Aug 03

A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)

Key Insights Avient's estimated fair value is US$37.54 based on 2 Stage Free Cash Flow to Equity With US$42.83 share...

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($1.4B) de AVNT superan a sus pasivos a corto plazo ($803.1M).

Pasivo a largo plazo: Los activos a corto plazo ($1.4B) de AVNT no cubren sus pasivos a largo plazo ($2.7B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de AVNT (61.9%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de AVNT ha pasado de 109% a 79.6% en los últimos 5 años.

Cobertura de la deuda: La deuda de AVNT no está bien cubierta por el flujo de caja operativo (16.5%).

Cobertura de intereses: Los pagos de intereses de la deuda de AVNT están bien cubiertos por el BAIT (8.2x cobertura).


Hoja de balance


Descubre empresas con salud financiera

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/20 15:53
Precio de las acciones al final del día2026/05/20 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Avient Corporation está cubierta por 18 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Ghansham PanjabiBaird
Prashant JuvekarCitigroup Inc
David BegleiterDeutsche Bank